Add Company
Join Now

Multidisciplinary Association for Psychedelic Studies Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Multidisciplinary Association for Psychedelic Studies's estimated annual revenue is currently $14.2M per year.(i)
  • Multidisciplinary Association for Psychedelic Studies's estimated revenue per employee is $102,000

Employee Data

  • Multidisciplinary Association for Psychedelic Studies has 139 Employees.(i)
  • Multidisciplinary Association for Psychedelic Studies grew their employee count by -9% last year.

Multidisciplinary Association for Psychedelic Studies's People

NameTitleEmail/Phone
1
VP Finance & PhilanthropyReveal Email/Phone
2
Communications OfficerReveal Email/Phone
3
Communications OfficerReveal Email/Phone
4
Communications OfficerReveal Email/Phone
5
VP MarketingReveal Email/Phone
6
Associate Director Annual GivingReveal Email/Phone
7
Major Gifts OfficerReveal Email/Phone
8
Medical Director, Clinical ScienceReveal Email/Phone
9
Justice, Equity, Diversity, Inclusion (JEDI) OfficerReveal Email/Phone
10
Director Development at Multidisciplinary Association for Psychedelic Studies (MAPS)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M13-7%N/AN/A
#2
$0.4M80%N/AN/A
#3
$16.3M1451%N/AN/A
#4
$5.2M574%N/AN/A
#5
$6.6M724%N/AN/A
#6
$9.1M896%N/AN/A
#7
$3.5M4310%N/AN/A
#8
$20.3M1811%N/AN/A
#9
$20.6M1844%N/AN/A
#10
$6.2M67-1%N/AN/A
Add Company

What Is Multidisciplinary Association for Psychedelic Studies?

Non-Profit & Professional Orgs.

keywords:N/A

N/A

Total Funding

139

Number of Employees

$14.2M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Multidisciplinary Association for Psychedelic Studies News

2022-04-20 - Challenges For Psychedelic Therapists

Psychedelic-assisted therapists are taught to use ... a clinical trial by the Multidisciplinary Association for Psychedelic Studies (MAPS),...

2022-04-17 - A psychedelic therapist allegedly took millions from a ...

Meanwhile, Sarlo pledged $1 million to the Multidisciplinary Association for Psychedelic Studies at Dulai's urging, the petition says,...

2022-03-22 - Numinus Completes First MDMA Administration in PTSD Trial ...

... study of MDMA-assisted psychotherapy for PTSD (MAPPUSX)" sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS)...

2020-08-25 - ATAI adds MD­MA biotech to grow­ing list of psy­che­del­ic mak­ers; Aca­dia adds $52.5M up­front pain buy­out

For years, the biggest push in psy­che­del­ic drug de­vel­op­ment has been around MD­MA, a par­ty drug long thought to have po­ten­tial ben­e­fits for pa­tients with PTSD. Rick Doblin, for years psy­che­del­ic ther­a­py’s most promi­nent ad­vo­cate and fundrais­er, and his non-prof­it, MAPS, hav ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A13972%N/A
#2
$38M1417%N/A
#3
$7.5M1452%N/A
#4
$40.9M14822%N/A
#5
N/A14969%N/A